Subscribe for the Newsletter

Mobile Navigation

Company Info

Impel NeuroPharma

Impel NeuroPharma

Drug Discovery & Development

Overview

Impel NeuroPharma, Inc., is a privately-held, Seattle-based biotechnology company devoted to creating life-changing, innovative therapies for central nervous system (CNS) diseases. Impel NeuroPharma is currently investigating INP104 (POD-DHE) for acute migraine headache, INP103 (POD-levodopa) for reversal of OFF episodes in Parkinson's disease and INP105 (POD-olanzapine) for acute agitation in schizophrenia and bipolar disorders.

Impel's products utilize its novel, nasal drug-delivery Precision Olfactory Delivery, or POD™, device technology to deliver liquid or dry powder forms of drug to the upper nasal cavity in a consistent and predictable manner. 

IMPEL, POD and the IMPEL Logo are trademarks of Impel NeuroPharma, Inc. 

Impel NeuroPharma
Contributions
Nice Insight is the market research division of That's Nice LLC, the leading marketing agency serving life sciences.
Subscribe for the newsletter
© 2026 PHARMA'S ALMANAC. All rights reserved.